Exact Mass: 381.1688

Exact Mass Matches: 381.1688

Found 205 metabolites which its exact mass value is equals to given mass value 381.1688, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

cis-Zeatin-7-N-glucoside

(2R,3R,4S,5S,6R)-2-(6-{[(2Z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-7H-purin-7-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


Cis-zeatin-7-N-glucoside is an intermediate in cytokinins 7-N-glucoside biosynthesis. It is generated from cis-zeatin via the enzyme UDP glycosyltransferase.Several types of cytokinins conjugation exist which render cytokinins inactive: O-xylosylation, O-glucosylation, and N-glucosylation. When plants are subjected to high levels of cytokinin application, the major conjugate that forms is the 7-N-glucoside. Moreover, unlike O-glucosides, the glucosylation of which is reversible through the action of glucosidases, 7-N- and 9-N-glucosides are resistant to glucosidases. This, taken with N-glucosides accumulation in plant subjected to high doses of cytokinins, has led to the suggestion that N-glucosylation is involved in detoxification. [HMDB] cis-Zeatin-7-N-glucoside is an intermediate in cytokinins 7-N-glucoside biosynthesis. It is generated from cis-zeatin via the enzyme UDP glycosyltransferase. Several types of cytokinins conjugation exist which render cytokinins inactive: O-xylosylation, O-glucosylation, and N-glucosylation. When plants are subjected to high levels of cytokinin application, the major conjugate that forms is the 7-N-glucoside. Moreover, unlike O-glucosides, the glucosylation of which is reversible through the action of glucosidases, 7-N- and 9-N-glucosides are resistant to glucosidases. This, taken with N-glucosides accumulation in plants subjected to high doses of cytokinins, has led to the suggestion that N-glucosylation is involved in detoxification. D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins

   

Azelastine

4-((4-Chlorophenyl)methyl)-2- (hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)- phthalazinone HCL

C22H24ClN3O (381.1608)


Azelastine is only found in individuals that have used or taken this drug. It is a phthalazine derivative, and is an antihistamine and mast cell stabilizer available as a nasal spray for hay fever and as eye drops for allergic conjunctivitis.Azelastine competes with histamine for the H1-receptor sites on effector cells and acts as an antagonist by inhibiting the release of histamine and other mediators involved in the allergic response. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors CONFIDENCE standard compound; INTERNAL_ID 8508 CONFIDENCE standard compound; INTERNAL_ID 2734 D018926 - Anti-Allergic Agents

   

6-(4-O-beta-D-Glucosyl-3-methyl-trans-but-2-enyl-amino)-purine

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(2E)-2-methyl-4-[(1H-purin-6-yl)amino]but-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H23N5O6 (381.1648)


6-(4-o-beta-d-glucosyl-3-methyl-trans-but-2-enyl-amino)-purine, also known as trans-zeatin-O-glucoside or O-beta-D-glucosylzeatin, is a member of the class of compounds known as fatty acyl glycosides of mono- and disaccharides. Fatty acyl glycosides of mono- and disaccharides are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol or of a phosphorylated alcohol (phosphoprenols), a hydroxy fatty acid or to one carboxyl group of a fatty acid (ester linkage) or to an amino alcohol. 6-(4-o-beta-d-glucosyl-3-methyl-trans-but-2-enyl-amino)-purine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 6-(4-o-beta-d-glucosyl-3-methyl-trans-but-2-enyl-amino)-purine can be found in a number of food items such as yellow wax bean, common verbena, black elderberry, and sacred lotus, which makes 6-(4-o-beta-d-glucosyl-3-methyl-trans-but-2-enyl-amino)-purine a potential biomarker for the consumption of these food products.

   

Petasitenine

(1R,3R,4R,6R,7R,11Z)-7-hydroxy-3,6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2-oxiran]-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


Alkaloid from Petasites japonicus (sweet coltsfoot). Petasitenine is found in giant butterbur and green vegetables. Petasitenine is found in giant butterbur. Petasitenine is an alkaloid from Petasites japonicus (sweet coltsfoot

   

cis-Zeatin O-glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(2Z)-2-methyl-4-[(1H-purin-6-yl)amino]but-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H23N5O6 (381.1648)


cis-Zeatin O-glucoside, also known as O-beta-D-glucosylzeatin, belongs to the class of organic compounds known as fatty acyl glycosides of mono- and disaccharides. Fatty acyl glycosides of mono- and disaccharides are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol, a phosphorylated alcohol (phosphoprenol), or a hydroxy fatty acid, or to one carboxyl group of a fatty acid (ester linkage) or an amino alcohol. cis-Zeatin O-glucoside is a very strong basic compound (based on its pKa). cis-Zeatin O-glucoside is an intermediate in zeatin biosynthesis. It is generated from cis-zeatin via the enzyme cis-zeatin O-beta-D-glucosyltransferase (EC 2.4.1.215).

   

cis-Zeatin-9-N-glucoside

(2R,3R,4S,5S,6R)-2-(6-{[(2Z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


Cis-zeatin-9-N-glucoside is an intermediate in cytokinins 9-N-glucoside biosynthesis. It is generated from cis-zeatin via the enzyme UDP glycosyltransferase.Glucosylation of cytokinins is a well recognized modification that is thought to play an important role in hormonal homeostasis. Several types of cytokinins conjugation exist which render cytokinins inactive: O-xylosylation, O-glucosylation, and N-glucosylation. [HMDB] cis-Zeatin-9-N-glucoside is an intermediate in cytokinins 9-N-glucoside biosynthesis. It is generated from cis-zeatin via the enzyme UDP glycosyltransferase. Glucosylation of cytokinins is a well-recognized modification that is thought to play an important role in hormonal homeostasis. Several types of cytokinins conjugation exist which render cytokinins inactive: O-xylosylation, O-glucosylation, and N-glucosylation.

   

(R)-Pantothenic acid 4'-O-b-D-glucoside

3-[(1,2-Dihydroxy-3,3-dimethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butylidene)amino]propanoate

C15H27NO10 (381.1635)


(R)-Pantothenic acid 4-O-b-D-glucoside is found in garden tomato. (R)-Pantothenic acid 4-O-b-D-glucoside is isolated from tomato juice. Isolated from tomato juice. (R)-Pantothenic acid 4-O-b-D-glucoside is found in garden tomato.

   

Raphanatin

(3R,4S,5S,6R)-2-(6-{[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-7H-purin-7-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


Raphanatin is found in root vegetables. Raphanatin is produced by Raphanus sativus (radish

   

2-Hydroxy-4-carboxybutyrylhistidylprolinamide

5-[[1-(2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-hydroxy-5-oxopentanoic acid

C16H23N5O6 (381.1648)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

sinefungin

2,5-diamino-6-[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid

C15H23N7O5 (381.1761)


   

Xaliproden

1-(2-(Naphth-2-yl)ethyl)-4-(3-trifluoromethylphenyl)-1,2,5,6-tetrahydropyridine hydrochloride

C24H22F3N (381.1704)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C26170 - Protective Agent > C1509 - Neuroprotective Agent N - Nervous system

   

(E)-Zeatin glucoside

2-(hydroxymethyl)-6-{[(2E)-2-methyl-4-[(9H-purin-6-yl)amino]but-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H23N5O6 (381.1648)


(e)-zeatin glucoside is a member of the class of compounds known as fatty acyl glycosides of mono- and disaccharides. Fatty acyl glycosides of mono- and disaccharides are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol or of a phosphorylated alcohol (phosphoprenols), a hydroxy fatty acid or to one carboxyl group of a fatty acid (ester linkage) or to an amino alcohol (e)-zeatin glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). (e)-zeatin glucoside can be found in soy bean, which makes (e)-zeatin glucoside a potential biomarker for the consumption of this food product.

   
   
   
   

12,13-Dihydro-12-hydroxyaustamide

12,13-Dihydro-12-hydroxyaustamide

C21H23N3O4 (381.1688)


   
   

(+)-Cyclotryprostatin C

(+)-Cyclotryprostatin C

C21H23N3O4 (381.1688)


   

Senecioracenine

Senecioracenine

C19H27NO7 (381.1787)


   

Zeatin 9-glucoside

Zeatin 9-glucoside

C16H23N5O6 (381.1648)


   

Adenosyl-Ornithine;A-9145;Antibiotic 32232RP

Adenosyl-Ornithine;A-9145;Antibiotic 32232RP

C15H23N7O5 (381.1761)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

   
   

TRANS-ZEATIN GLUCOSIDE

O-beta-D-Glucosyl-trans-zeatin

C16H23N5O6 (381.1648)


The trans-isomer of O-beta-D-glucosylzeatin.

   
   
   
   

12-O-acetylhadiensine

12-O-acetylhadiensine

C19H27NO7 (381.1787)


   

18-hydroxy-senkirkine

18-hydroxy-senkirkine

C19H27NO7 (381.1787)


   

bruceolline F

bruceolline F

C19H27NO7 (381.1787)


An indole alkaloid that is 1H-indole substituted by a (2S)-2,3-dihydroxy-3-methylbutyl group at position 3 and a beta-D-glucopyranosyl group attached to the indolic nitrogen. It has been isolated from the ethanol extract of the stems of Brucea mollis.

   
   

nitrocadambine B

nitrocadambine B

C21H23N3O4 (381.1688)


   

sceavodimerine B

sceavodimerine B

C21H23N3O4 (381.1688)


   
   
   
   
   
   

(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)pentanedioic acid

(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)pentanedioic acid

C16H23N5O6 (381.1648)


   
   
   
   

Otosenin

(1R,3S,4S,6R,7R,11Z)-7-hydroxy-3,6,7,14-tetramethyl-3H,8H,17H-spiro[2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-4,2-oxirane]-3,8,17-trione

C19H27NO7 (381.1787)


Otosenine is a pyrrolizine alkaloid that is produced by several Jacobaea and Senecio species. It has a role as a Jacobaea metabolite. It is a macrocyclic lactone, a tertiary amino compound, a tertiary alcohol, a pyrrolizine alkaloid, an organic heterobicyclic compound, a spiro-epoxide and an enone. Otosenine is a natural product found in Doronicum austriacum, Doronicum macrophyllum, and other organisms with data available. A pyrrolizine alkaloid that is produced by several Jacobaea and Senecio species.

   

Trans-Zeatin-9-glucoside

Trans-Zeatin-9-glucoside

C16H23N5O6 (381.1648)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Trans-Zeatin-9-glucoside-[d5]

Trans-Zeatin-9-glucoside-[d5]

C16H23N5O6 (381.1648)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

trans-Zeatin-O-glucoside

trans-Zeatin-O-glucoside

C16H23N5O6 (381.1648)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Trans-Zeatin-7-glucoside-[d5]

Trans-Zeatin-7-glucoside-[d5]

C16H23N5O6 (381.1648)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

cis-Zeatin-9-glucoside

cis-Zeatin-9-glucoside

C16H23N5O6 (381.1648)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

cis-Zeatin-O-glucoside

O-beta-D-Glucopyranosyl-cis-zeatin

C16H23N5O6 (381.1648)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

trans-Zeatin-7-glucoside

trans-Zeatin-7-glucoside

C16H23N5O6 (381.1648)


   

Otosenine

Otosenine

C19H27NO7 (381.1787)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.260 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.248

   
   

azelastine

azelastine

C22H24ClN3O (381.1608)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D018926 - Anti-Allergic Agents

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

cis-Zeatin-7-N-glucoside

cis-Zeatin-7-N-glucoside

C16H23N5O6 (381.1648)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins

   

cis-Zeatin-9-N-glucoside

cis-Zeatin-9-N-glucoside

C16H23N5O6 (381.1648)


   

Raphanatin

(3R,4S,5S,6R)-2-(6-{[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-7H-purin-7-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins

   

(R)-Pantothenic acid 4'-O-b-D-glucoside

3-[2-hydroxy-3-methyl-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)butanamido]propanoic acid

C15H27NO10 (381.1635)


   

cis-Zeatin 9-glucoside

2-(6-{[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

Ethyl N-Boc-4-(4-chlorobenzyl)piperidine-4-carboxylate

Ethyl N-Boc-4-(4-chlorobenzyl)piperidine-4-carboxylate

C20H28ClNO4 (381.1707)


   

(Rac)-Ambrisentan-d3

(Rac)-Ambrisentan-d3

C22H19D3N2O4 (381.1768)


   

Solvent Red 197

Solvent Red 197

C23H19N5O (381.159)


   

(3R,4S)-1-Benzoyl-4-phenyl-3-[(triethylsilyl)oxy]-2-azetidinone

(3R,4S)-1-Benzoyl-4-phenyl-3-[(triethylsilyl)oxy]-2-azetidinone

C22H27NO3Si (381.176)


   

4-AMINO-2-OXO-PYRIMIDINYL-OXATHIOLANE-2-CARBOXYLIC ACID-ISOPROPYL-METHYL-CYCLOHEXYL ESTER

4-AMINO-2-OXO-PYRIMIDINYL-OXATHIOLANE-2-CARBOXYLIC ACID-ISOPROPYL-METHYL-CYCLOHEXYL ESTER

C18H27N3O4S (381.1722)


   

Urea, N-[(2-chloro-6,8-dimethyl-3-quinolinyl)methyl]-N-(1-methylethyl)-N-phenyl- (9CI)

Urea, N-[(2-chloro-6,8-dimethyl-3-quinolinyl)methyl]-N-(1-methylethyl)-N-phenyl- (9CI)

C22H24ClN3O (381.1608)


   

2-benzhydryloxyethyl(trimethyl)azanium,methyl sulfate

2-benzhydryloxyethyl(trimethyl)azanium,methyl sulfate

C19H27NO5S (381.161)


   

(2R-CIS)-5-(4-AMINO-1,2-DIHYDRO-2-OXO-1-PYRIMIDINYL)

(2R-CIS)-5-(4-AMINO-1,2-DIHYDRO-2-OXO-1-PYRIMIDINYL)

C18H27N3O4S (381.1722)


   

Boc-tyr(boc)-oh

Boc-tyr(boc)-oh

C19H27NO7 (381.1787)


   
   

Bevantolol hydrochloride

Bevantolol hydrochloride

C20H28ClNO4 (381.1707)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Bevantolol hydrochloride is a selective β1 and α1-adrenergic receptor antagonist with pKi values of 7.83, 6.9 in rat cerebral cortex, respectively. Bevantolol hydrochloride is a potent Ca2+ antagonist[1][2].

   

4-acrylamidobenzo-18-crown-6, 98

4-acrylamidobenzo-18-crown-6, 98

C19H27NO7 (381.1787)


   

4-[(4-chlorophenyl)methyl]-2-[2-(1-methylpyrrolidin-2-yl)ethyl]phthalazin-1-one

4-[(4-chlorophenyl)methyl]-2-[2-(1-methylpyrrolidin-2-yl)ethyl]phthalazin-1-one

C22H24ClN3O (381.1608)


   

Sinefungin

Sinefungin

C15H23N7O5 (381.1761)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents An adenosine that is the the delta-(5-adenosyl) derivative of ornithine. D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent COVID info from PDB, Protein Data Bank C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Disperse Red 277

Disperse Red 277

C23H19N5O (381.159)


   

LJH-685

LJH-685

C22H21F2N3O (381.1653)


LJH685 is a potent, ATP-competitive and selective RSK inhibitor, inhibits RSK1, 2, and 3 biochemical activities with IC50s of 6, 5, 4 nM, respectively[1].

   

N,O-Di-BOC-D-tyrosine

N,O-Di-BOC-D-tyrosine

C19H27NO7 (381.1787)


   

N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid

N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid

C15H23N7O5 (381.1761)


   

Esmirtazapine maleate

Esmirtazapine maleate

C21H23N3O4 (381.1688)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   
   

3-[1-butyl-5-(diethylsulfamoyl)-1H-1,3-benzodiazol-2-yl]propanoic acid

3-[1-butyl-5-(diethylsulfamoyl)-1H-1,3-benzodiazol-2-yl]propanoic acid

C18H27N3O4S (381.1722)


   

Pyrametostrobin

Pyrametostrobin

C21H23N3O4 (381.1688)


   

H-Pro-his-glu-OH

H-Pro-his-glu-OH

C16H23N5O6 (381.1648)


   

[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile

[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile

C22H19N7 (381.1702)


   

[4-({4-[(5-Cyclopropyl-1h-Pyrazol-3-Yl)amino]quinazolin-2-Yl}imino)cyclohexa-2,5-Dien-1-Yl]acetonitrile

[4-({4-[(5-Cyclopropyl-1h-Pyrazol-3-Yl)amino]quinazolin-2-Yl}imino)cyclohexa-2,5-Dien-1-Yl]acetonitrile

C22H19N7 (381.1702)


   

Xaliproden

Xaliproden

C24H22F3N (381.1704)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C26170 - Protective Agent > C1509 - Neuroprotective Agent N - Nervous system

   

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2E)-2-methyl-4-[(7H-purin-6-yl)amino]but-2-en-1-yl]oxy}oxane-3,4,5-triol

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2E)-2-methyl-4-[(7H-purin-6-yl)amino]but-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

trans-zeatin-9-N-glucoside

trans-zeatin-9-N-glucoside

C16H23N5O6 (381.1648)


   

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-7-yl]oxane-3,4,5-triol

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-7-yl]oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

trans-Zeatin-7-N-glucoside

trans-Zeatin-7-N-glucoside

C16H23N5O6 (381.1648)


   

(2S,5S)-2,5-diamino-6-[(2R,3S,4R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid

(2S,5S)-2,5-diamino-6-[(2R,3S,4R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid

C15H23N7O5 (381.1761)


   

1-[2-Fluoro-4,5-bis(phenylmethoxy)phenyl]-2-(methylamino)ethanol

1-[2-Fluoro-4,5-bis(phenylmethoxy)phenyl]-2-(methylamino)ethanol

C23H24FNO3 (381.174)


   

N-[2-(3,4-dimethoxyphenyl)ethyl]-5-(2-hydroxy-5-methylphenyl)-1H-pyrazole-3-carboxamide

N-[2-(3,4-dimethoxyphenyl)ethyl]-5-(2-hydroxy-5-methylphenyl)-1H-pyrazole-3-carboxamide

C21H23N3O4 (381.1688)


   
   

(5R)-1-[2-[3,5-bis(trifluoromethyl)phenyl]ethyl]-5-butyl-4,5-dihydroimidazol-2-amine

(5R)-1-[2-[3,5-bis(trifluoromethyl)phenyl]ethyl]-5-butyl-4,5-dihydroimidazol-2-amine

C17H21F6N3 (381.164)


   

1-[(6-nitro-1,3-benzodioxol-5-yl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine

1-[(6-nitro-1,3-benzodioxol-5-yl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine

C21H23N3O4 (381.1688)


   

N-[4-(4-acetyl-1-piperazinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-carboxamide

N-[4-(4-acetyl-1-piperazinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-carboxamide

C21H23N3O4 (381.1688)


   

1-(1,3-benzodioxol-5-ylmethyl)-4-[(E)-3-(2-nitrophenyl)prop-2-enyl]piperazine

1-(1,3-benzodioxol-5-ylmethyl)-4-[(E)-3-(2-nitrophenyl)prop-2-enyl]piperazine

C21H23N3O4 (381.1688)


   

N-(3,5-dimethoxyphenyl)-2-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolyl)acetamide

N-(3,5-dimethoxyphenyl)-2-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolyl)acetamide

C21H23N3O4 (381.1688)


   
   
   

1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol hydrochloride

1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol hydrochloride

C20H28ClNO4 (381.1707)


   

2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H23N3O4 (381.1688)


   

2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H23N3O4 (381.1688)


   

2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(2-pyridin-3-ylacetyl)amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H23N3O4 (381.1688)


   

2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H23N3O4 (381.1688)


   

2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H23N3O4 (381.1688)


   

2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H23N3O4 (381.1688)


   

(1R,2aS,8bS)-2-acetyl-1-(hydroxymethyl)-N-(2-methoxyphenyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1R,2aS,8bS)-2-acetyl-1-(hydroxymethyl)-N-(2-methoxyphenyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H23N3O4 (381.1688)


   

(1S,2aS,8bS)-2-acetyl-1-(hydroxymethyl)-N-(2-methoxyphenyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aS,8bS)-2-acetyl-1-(hydroxymethyl)-N-(2-methoxyphenyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H23N3O4 (381.1688)


   

(6R,7R,8R)-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C21H23N3O4 (381.1688)


   

(6S,7S,8R)-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C21H23N3O4 (381.1688)


   

2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H23N3O4 (381.1688)


   

2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H23N3O4 (381.1688)


   

(1S,2aR,8bR)-2-acetyl-1-(hydroxymethyl)-N-(2-methoxyphenyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aR,8bR)-2-acetyl-1-(hydroxymethyl)-N-(2-methoxyphenyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H23N3O4 (381.1688)


   

(1R,2aR,8bR)-2-acetyl-1-(hydroxymethyl)-N-(2-methoxyphenyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1R,2aR,8bR)-2-acetyl-1-(hydroxymethyl)-N-(2-methoxyphenyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H23N3O4 (381.1688)


   

(6S,7S,8S)-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C21H23N3O4 (381.1688)


   

(6R,7R,8S)-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C21H23N3O4 (381.1688)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(R)-bevantolol hydrochloride

(R)-bevantolol hydrochloride

C20H28ClNO4 (381.1707)


   

(S)-bevantolol hydrochloride

(S)-bevantolol hydrochloride

C20H28ClNO4 (381.1707)


   

Zeatin-7-N-glucoside

Zeatin-7-N-glucoside

C16H23N5O6 (381.1648)


   

Fucalpha1-3GlcNAcalphaOMe

Fucalpha1-3GlcNAcalphaOMe

C15H27NO10 (381.1635)


   

(1R,3S,4S,6R,7S,11Z)-7-hydroxy-3,6,7,14-tetramethylspiro[2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-4,2-oxirane]-3,8,17-trione

(1R,3S,4S,6R,7S,11Z)-7-hydroxy-3,6,7,14-tetramethylspiro[2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-4,2-oxirane]-3,8,17-trione

C19H27NO7 (381.1787)


   

9-(beta-D-glucosyl)-cis-zeatin

9-(beta-D-glucosyl)-cis-zeatin

C16H23N5O6 (381.1648)


An N-glycosylzeatin that is cis-zeatin having a beta-D-glucopyranosyl residue attached at position N-9.

   
   

(R)-Pantothenic acid 4-O-b-D-glucoside

(R)-Pantothenic acid 4-O-b-D-glucoside

C15H27NO10 (381.1635)


   

9-(beta-D-glucosyl)-trans-zeatin

9-(beta-D-glucosyl)-trans-zeatin

C16H23N5O6 (381.1648)


An N-glycosylzeatin that is trans-zeatin having a beta-D-glucopyranosyl residue attached at position N-9.

   

7-(beta-D-glucosyl)-cis-zeatin

7-(beta-D-glucosyl)-cis-zeatin

C16H23N5O6 (381.1648)


An N-glycosylzeatin that is cis-zeatin having a beta-D-glucopyranosyl residue attached at position N-7.

   
   

4-(methoxycarbonyl)-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridin-6-yl 1-methyl-2,7-naphthyridine-4-carboxylate

4-(methoxycarbonyl)-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridin-6-yl 1-methyl-2,7-naphthyridine-4-carboxylate

C21H23N3O4 (381.1688)


   

2-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-9-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-9-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

(3r)-3-[(2s,3as,5as,8s,9ar,9br)-8-chloro-3a,6,6,9a-tetramethyl-5-oxo-octahydronaphtho[2,1-b]furan-2-yl]-5-hydroxy-3,4-dihydropyrrol-2-one

(3r)-3-[(2s,3as,5as,8s,9ar,9br)-8-chloro-3a,6,6,9a-tetramethyl-5-oxo-octahydronaphtho[2,1-b]furan-2-yl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H28ClNO4 (381.1707)


   

1,2-dihydroxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

1,2-dihydroxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C21H23N3O4 (381.1688)


   

7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

2-[3-(2,3-dihydroxy-3-methylbutyl)indol-1-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[3-(2,3-dihydroxy-3-methylbutyl)indol-1-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

C19H27NO7 (381.1787)


   

(3r)-3-[(1s)-2-[(1s,4ar,6s,8ar)-6-chloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

(3r)-3-[(1s)-2-[(1s,4ar,6s,8ar)-6-chloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H28ClNO4 (381.1707)


   

(1s,3'r,4s,6s,7r,11z)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

(1s,3'r,4s,6s,7r,11z)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

(2r,3s,4r,5s,6r)-2-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-7-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4r,5s,6r)-2-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-7-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

(1r,4z,6r,7s,11z)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6,14-dimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

(1r,4z,6r,7s,11z)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6,14-dimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(2e)-2-methyl-4-(3h-purin-6-ylamino)but-2-en-1-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(2e)-2-methyl-4-(3h-purin-6-ylamino)but-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

2-(hydroxymethyl)-6-{[2-methyl-4-(3h-purin-6-ylamino)but-2-en-1-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[2-methyl-4-(3h-purin-6-ylamino)but-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

methyl (1s,9s,10s,11e,14s,15s)-11-ethylidene-17-hydroxy-18-oxa-8,13,16-triazahexacyclo[11.5.2.1¹⁰,¹⁴.0¹,¹⁵.0²,⁷.0⁸,¹⁵]henicosa-2,4,6,16-tetraene-9-carboxylate

methyl (1s,9s,10s,11e,14s,15s)-11-ethylidene-17-hydroxy-18-oxa-8,13,16-triazahexacyclo[11.5.2.1¹⁰,¹⁴.0¹,¹⁵.0²,⁷.0⁸,¹⁵]henicosa-2,4,6,16-tetraene-9-carboxylate

C21H23N3O4 (381.1688)


   

(1r,2s,12s,15s)-1,2-dihydroxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

(1r,2s,12s,15s)-1,2-dihydroxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C21H23N3O4 (381.1688)


   

3'-hydroxy-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecan]-13'-ene-2',3,8'-trione

3'-hydroxy-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecan]-13'-ene-2',3,8'-trione

C21H23N3O4 (381.1688)


   

(1r,2s,3s,9r)-5-ethanimidoyl-1,4-dihydroxy-8,8,16-trimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-4,11,13,15(18)-tetraene-6,17-dione

(1r,2s,3s,9r)-5-ethanimidoyl-1,4-dihydroxy-8,8,16-trimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-4,11,13,15(18)-tetraene-6,17-dione

C21H23N3O4 (381.1688)


   

3-[2-(6-chloro-5,5,8a-trimethyl-2-methylidene-4-oxo-hexahydronaphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

3-[2-(6-chloro-5,5,8a-trimethyl-2-methylidene-4-oxo-hexahydronaphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H28ClNO4 (381.1707)


   

trans-zeatin-7-β-d-glucoside

trans-zeatin-7-β-d-glucoside

C16H23N5O6 (381.1648)


   

(2s,3r,4r,5s,6s)-2-(hydroxymethyl)-6-{[(2z)-2-methyl-4-(3h-purin-6-ylamino)but-2-en-1-yl]oxy}oxane-3,4,5-triol

(2s,3r,4r,5s,6s)-2-(hydroxymethyl)-6-{[(2z)-2-methyl-4-(3h-purin-6-ylamino)but-2-en-1-yl]oxy}oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

(2s)-2-{[(3r)-3,4-dicarbamimidamido-1-hydroxybutylidene]amino}-3-(3,4-dihydroxyphenyl)propanoic acid

(2s)-2-{[(3r)-3,4-dicarbamimidamido-1-hydroxybutylidene]amino}-3-(3,4-dihydroxyphenyl)propanoic acid

C15H23N7O5 (381.1761)


   

(1r,3'r,4r,6r,7r,11e)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

(1r,3'r,4r,6r,7r,11e)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

3-[2-(7-chloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

3-[2-(7-chloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H28ClNO4 (381.1707)


   

(2r,3r,4s,5s,6r)-2-[2-hydroxy-6-imino-3-(3-methylbut-2-en-1-yl)purin-7-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-[2-hydroxy-6-imino-3-(3-methylbut-2-en-1-yl)purin-7-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

(3r)-3-[(1s)-2-[(1s,4ar,6s,8ar)-6-chloro-5,5,8a-trimethyl-2-methylidene-4-oxo-hexahydronaphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

(3r)-3-[(1s)-2-[(1s,4ar,6s,8ar)-6-chloro-5,5,8a-trimethyl-2-methylidene-4-oxo-hexahydronaphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H28ClNO4 (381.1707)


   

4-ethylidene-7-hydroxy-6-(hydroxymethyl)-7,14-dimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

4-ethylidene-7-hydroxy-6-(hydroxymethyl)-7,14-dimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

(1r,3's,4s,6s,7r,11z)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

(1r,3's,4s,6s,7r,11z)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

(3r)-3-[(1s)-2-[(1s,4as,7s,8ar)-7-chloro-5,5,8a-trimethyl-2-methylidene-4-oxo-hexahydronaphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

(3r)-3-[(1s)-2-[(1s,4as,7s,8ar)-7-chloro-5,5,8a-trimethyl-2-methylidene-4-oxo-hexahydronaphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H28ClNO4 (381.1707)


   

1,8,8a-trihydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

1,8,8a-trihydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O4 (381.1688)


   

4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6,14-dimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6,14-dimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

(1r,2r,4s,5r,7r,11s,12s,15s,23r)-4-amino-11-hydroxy-18-methoxy-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17(22),18,20-trien-3-one

(1r,2r,4s,5r,7r,11s,12s,15s,23r)-4-amino-11-hydroxy-18-methoxy-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17(22),18,20-trien-3-one

C21H23N3O4 (381.1688)


   

(1r,4z,6r,7r,11z)-4-ethylidene-7-hydroxy-6-(hydroxymethyl)-7,14-dimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

(1r,4z,6r,7r,11z)-4-ethylidene-7-hydroxy-6-(hydroxymethyl)-7,14-dimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

(1r,3'r,4r,6r,7r)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

(1r,3'r,4r,6r,7r)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

5-ethanimidoyl-1,4-dihydroxy-8,8,16-trimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-4,11,13,15(18)-tetraene-6,17-dione

5-ethanimidoyl-1,4-dihydroxy-8,8,16-trimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-4,11,13,15(18)-tetraene-6,17-dione

C21H23N3O4 (381.1688)


   

(1r,2r,4r,5r,7r,11s,12s,15s,23r)-4-amino-11-hydroxy-18-methoxy-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17(22),18,20-trien-3-one

(1r,2r,4r,5r,7r,11s,12s,15s,23r)-4-amino-11-hydroxy-18-methoxy-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17(22),18,20-trien-3-one

C21H23N3O4 (381.1688)


   

(4as,6s,7r,7as)-4-(methoxycarbonyl)-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridin-6-yl 1-methyl-2,7-naphthyridine-4-carboxylate

(4as,6s,7r,7as)-4-(methoxycarbonyl)-7-methyl-1h,2h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyridin-6-yl 1-methyl-2,7-naphthyridine-4-carboxylate

C21H23N3O4 (381.1688)


   

3-[2-(6-chloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

3-[2-(6-chloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H28ClNO4 (381.1707)


   

2-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-7-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-7-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

(2r,3'r,9's)-3'-hydroxy-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecan]-13'-ene-2',3,8'-trione

(2r,3'r,9's)-3'-hydroxy-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecan]-13'-ene-2',3,8'-trione

C21H23N3O4 (381.1688)


   

(1r,3'r,4r,6s,7r,11z)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

(1r,3'r,4r,6s,7r,11z)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

(2r,3r,4s,5s,6r)-2-{3-[(2r)-2,3-dihydroxy-3-methylbutyl]indol-1-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{3-[(2r)-2,3-dihydroxy-3-methylbutyl]indol-1-yl}-6-(hydroxymethyl)oxane-3,4,5-triol

C19H27NO7 (381.1787)


   

(3z)-1,8,8a-trihydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

(3z)-1,8,8a-trihydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O4 (381.1688)


   

(3r)-3-[(1s)-2-[(1s,4as,7s,8ar)-7-chloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

(3r)-3-[(1s)-2-[(1s,4as,7s,8ar)-7-chloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H28ClNO4 (381.1707)


   

(1r,3'r,6r)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

(1r,3'r,6r)-7-hydroxy-3',6,7,14-tetramethyl-2,9-dioxa-14-azaspiro[bicyclo[9.5.1]heptadecane-4,2'-oxiran]-11-ene-3,8,17-trione

C19H27NO7 (381.1787)


   

(2s)-2-{[(3s)-3,4-dicarbamimidamido-1-hydroxybutylidene]amino}-3-(3,4-dihydroxyphenyl)propanoic acid

(2s)-2-{[(3s)-3,4-dicarbamimidamido-1-hydroxybutylidene]amino}-3-(3,4-dihydroxyphenyl)propanoic acid

C15H23N7O5 (381.1761)


   

(2r,3r,4s,5s,6r)-2-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

C16H23N5O6 (381.1648)


   

2-[(3,4-dicarbamimidamido-1-hydroxybutylidene)amino]-3-(3,4-dihydroxyphenyl)propanoic acid

2-[(3,4-dicarbamimidamido-1-hydroxybutylidene)amino]-3-(3,4-dihydroxyphenyl)propanoic acid

C15H23N7O5 (381.1761)